NL-OMON51007招募中不适用
Comparison between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention - SLIM 2 study
Zuyderland Medisch Centrum0 个研究点目标入组 1,270 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,270
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •o Patients aged between 18-85 years using DOAC and undergoing elective ICA or
- •o Written informed consent
排除标准
- •- Patients initially presenting with Acute Coronary Syndrome (STEMI, NSTEMI, UA)
- •- Patients <18 or >85 years old
- •- Calculated CLCR <30 mL/min
- •- Patients simultaneously participating in another clinical trial
- •- History or condition associated with increased bleeding risk, as listed below:
- •o Major surgical procedure within 30 days before the procedure
- •o Known inaccessible radial artery during previous procedure
- •o History of GI bleeding in the previous 6 months
- •o History of intracranial, intraocular, spinal, or atraumatic intra-articular
- •o Chronic bleeding disorder
- •o Known intracranial neoplasm, arteriovenous malformation, or aneurysm
- •o Known anemia with last measured haemoglobin value <6 mmol/L [9.67 g/dL]
- •o Current pregnancy or breast-feeding
- •o Known significant liver disease (e.g., acute clinical hepatitis, chronic
- •active hepatitis, cirrhosis), or ALT >3 x the ULN
研究者
相似试验
招募中
Unknown
Comparative efficacy and safety of pill-in-the-pocket anticoagulation strategyDiseases of the circulatory systemKCT0008995Seoul National University Hospital400
已完成
不适用
Assessment of Direct Oral Anticoagulant Use and Clinical Outcomes among Patients with Kidney Impairment at Faculty of Medicine Siriraj HospitalPatients who were prescribed first DOACs between January 1, 2019 to December 31, 2020Direct oral anticoagulant, dosing, kidney impairmentTCTR20230703002Faculty of Medicine Siriraj Hospital Mahidol University320
招募中
不适用
Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary InterventionAnticoagulantsAtrial FibrillationCoronary Artery DiseaseNCT04977076Zuyderland Medisch Centrum1,270
已完成
2 期
Oral blood thinners versus injectable blood thinners in preventing clotting disorders associated with COVID 19 infectioCTRI/2021/05/033871Dhiraj Kumar230
招募中
不适用
The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF)atrial fibrillationJPRN-UMIN000030673Tokyo Medical and Dental University1,000